Injecting PrRP into the central nervous system (CNS) decreases feeding; conversely, disrupting Prlh in mice promotes obesity by increasing food intake and decreasing energy expenditure [[13], [14], [15], [16], [17], [18], [19]]. Here, PRLH is linked to obesity due to melanocortin 4 receptor deficiency.